European Molecular Biology Laboratory

For 2024, the European Molecular Biology Laboratory (EMBL) reported total Scope 1 emissions of 2,649 kg CO2e, Scope 2 emissions of 8,015 kg CO2e, and Scope 3 emissions of 48,149 kg CO2e. These Scope 3 emissions included 13,945 kg CO2e from capital goods, 3,697 kg CO2e from business travel, 34,000 kg CO2e from employee commute, 147,000 kg CO2e from upstream leased assets, 450,000 kg CO2e from downstream leased assets, 29,518 kg CO2e from purchased goods and services, and 358,000 kg CO2e from upstream transportation and distribution.

In 2023, EMBL's Scope 1 emissions were 2,381 kg CO2e, Scope 2 emissions were 7,786 kg CO2e, and Scope 3 emissions amounted to 40,625 kg CO2e. Key categories within Scope 3 for 2023 included 12,349 kg CO2e from capital goods, 3,523 kg CO2e from business travel, 28,000 kg CO2e from employee commute, 99,000 kg CO2e from upstream leased assets, 417,000 kg CO2e from downstream leased assets, 24,058 kg CO2e from purchased goods and services, and 151,000 kg CO2e from upstream transportation and distribution.

EMBL, based in Germany, operates in the research and development services sector. The organisation has not publicly disclosed specific, quantifiable carbon reduction targets, nor has it made commitments through initiatives such as the Science Based Targets initiative (SBTi) or The Climate Pledge.